Recap: Tokyo Forum 2024 – Life Science and R&D Investment

With nearly a third of Japan’s population aged at 65 or over, life science and R&D real estate presents a compelling opportunity for property investors seeking to capitalise on rising healthcare demand and increasing pharmaceutical research and development, according to senior executives from Warburg Pincus, Lendlease, and CBRE speaking at Mingtiandi’s 2024 Tokyo Forum. Watch the full recording>>